Myeloproliferative Neoplasms‐Unclassifiable ( MPN ‐U): A Carefully Curated Series of 30 Mayo Clinic Patients

Documenti analoghi

• Momelotinib expands the therapeutic armamentarium for myelofibrosis: Impact on hierarchy of treatment choices
  di: Ayalew Tefferi, et al.
  Pubblicazione: (2024)
• Therapeutic Targeting of the Activin Receptor Signaling Pathway: Proof of Concept in Myeloid Neoplasms
  di: Ayalew Tefferi, et al.
  Pubblicazione: (2025)
• Autoimmune myelofibrosis: A Mayo Clinic series of 22 patients
  di: Naseema Gangat, et al.
  Pubblicazione: (2024)
• Validation of BLAST and BLAST ‐Mol Risk Models in Chronic Myelomonocytic Leukemia: Mayo–Humanitas Collaborative Project Involving 1101 Patients
  di: Saubia Fathima, et al.
  Pubblicazione: (2025)
• Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases
  di: Saubia Fathima, et al.
  Pubblicazione: (2025)